1. Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics

   • Jeffrey Cummings

   Current Opinion Open access 15 April 2023 Pages: 569 - 576

2. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?

   • Ayedh K. Alamri
   • Christy L. Ma
   • John J. Ryan

   Leading Article 05 April 2023 Pages: 577 - 585

   

3. The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials

   • Bei Pan
   • Long Ge
   • Kehu Yang

   Systematic Review 22 March 2023 Pages: 587 - 619

   

4. Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study

   • Thomas Yen-Ting Chen
   • Shiow-Ing Wang
   • James Cheng-Chung Wei

   Original Research Article 10 May 2023 Pages: 621 - 632

   

5. Efanesoctocog Alfa: First Approval

   • Susan J. Keam

   AdisInsight Report Open access 06 April 2023 Pages: 633 - 638

   

6. Keverprazan Hydrochloride: First Approval

   • Connie Kang

   AdisInsight Report 19 April 2023 Pages: 639 - 643

   

7. Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’

   • Chia Siang Kow
   • Dinesh Sangarran Ramachandram
   • Syed Shahzad Hasan

   Letter to the Editor 04 May 2023 Pages: 645 - 646

8. Authors’ Reply to Chia Siang Kow et al.: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?’

   • Alexia Plocque
   • Francois Philippart

   Letter to the Editor 04 May 2023 Pages: 647 - 648